Skip to main content
Erschienen in: Current Treatment Options in Neurology 5/2016

01.05.2016 | Neuro-oncology (R Soffietti, Section Editor)

Neurocognitive Deficits and Neurocognitive Rehabilitation in Adult Brain Tumors

verfasst von: Julia Day, BSc (Hons), MScR, David C. Gillespie, MA (Hons), ClinPsyD, PhD, MSc (Fam Therapy), CPsychol, Alasdair G. Rooney, MBChB, MD, Helen J. Bulbeck, PhD, Karolis Zienius, MBChB, BSc, Florien Boele, PhD, Robin Grant, MBChB, MD

Erschienen in: Current Treatment Options in Neurology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Opinion statement

Neurocognitive deficits are common with brain tumors. If assessed at presentation using detailed neurocognitive tests, problems are detected in 80 % of cases. Neurocognition may be affected by the tumor, its treatment, associated medication, mood, fatigue, and insomnia. Interpretation of neurocognitive problems should be considered in the context of these factors. Early post-operative neurocognitive rehabilitation for brain tumor patients will produce rehabilitation outcomes (e.g., quality of life, improved physical function, subjective neurocognition) equivalent to stroke, multiple sclerosis, and head injury, but the effect size and duration of benefit needs further research. In stable patients treated with radiotherapy +/− chemotherapy, the most frequent causes of distress include neurocognitive problems, psychological factors of anxiety, depression, fatigue, and sleep. Exercise, neurocognitive training, neurocognitive behavioral therapy, and medications to treat fatigue, behavior, memory, mood, and removal of drugs that may be associated with neurocognitive side effects (e.g., anti-epileptic drugs) all show promise in helping patients to manage the effects of their neurocognitive impairments better. As these are complex symptoms, multidisciplinary expertise is necessary to evaluate the influence of each variable to plan appropriate support and intervention. Neurocognitive rehabilitation should therefore occur in parallel with disease-centered, medical management from the outset. It should not occur in series, as a restricted phase in a patient’s pathway. It should be considered in the pre- and post-operative period where there are good prospects of recovery, as one would for any brain-injured patient, so that the person may reach their optimal physical, sensory, intellectual, psychological, and social functional level. Yet the identification and selection of patients for early neurological rehabilitation and routine evaluation of cognition is uncommon in neurosurgical wards.
Literatur
1.
Zurück zum Zitat Lehmann J, De Lisa J, Warren C. Cancer rehabilitation assessment of need development and education of a model of care. Arch Phys Med Rehabil. 1978;59:410–9.PubMed Lehmann J, De Lisa J, Warren C. Cancer rehabilitation assessment of need development and education of a model of care. Arch Phys Med Rehabil. 1978;59:410–9.PubMed
2.
Zurück zum Zitat Grant R. Overview: brain tumour diagnosis and management/Royal College of Physicians guidelines. J Neurol Neurosurg Psychiatry. 2004;75:18–23.CrossRef Grant R. Overview: brain tumour diagnosis and management/Royal College of Physicians guidelines. J Neurol Neurosurg Psychiatry. 2004;75:18–23.CrossRef
4.
Zurück zum Zitat Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.PubMedCrossRef Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.PubMedCrossRef
5.
Zurück zum Zitat Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. Years of life lost (YLL) from cancer is an important measure of population burden and should be considered when allocating research funds. Br J Cancer. 2005;92(2):241–5.PubMedPubMedCentral Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. Years of life lost (YLL) from cancer is an important measure of population burden and should be considered when allocating research funds. Br J Cancer. 2005;92(2):241–5.PubMedPubMedCentral
6.••
Zurück zum Zitat Wade D. Rehabilitation—a new approach. Overview and part one: the problems. Clin Rehabil. 2015;29(11):1041–50. This paper emphasizes the importance of early rehabilitation following brain injury for any cause.PubMedCrossRef Wade D. Rehabilitation—a new approach. Overview and part one: the problems. Clin Rehabil. 2015;29(11):1041–50. This paper emphasizes the importance of early rehabilitation following brain injury for any cause.PubMedCrossRef
7.
Zurück zum Zitat Lidstone V, Butters E, Seed PT, Sinnott C, Beynon T, Richards M. Symptoms and concerns among cancer outpatients: identifying the need for specialist palliative care. Palliat Med. 2003;17:588–95.PubMedCrossRef Lidstone V, Butters E, Seed PT, Sinnott C, Beynon T, Richards M. Symptoms and concerns among cancer outpatients: identifying the need for specialist palliative care. Palliat Med. 2003;17:588–95.PubMedCrossRef
8.
Zurück zum Zitat Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001;80(5):346–50.PubMedCrossRef Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001;80(5):346–50.PubMedCrossRef
9.
Zurück zum Zitat Taphoorn MJB, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159–68.PubMedCrossRef Taphoorn MJB, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159–68.PubMedCrossRef
10.
Zurück zum Zitat Chang EL, Wefel JS, Hess KR, Allen PK, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomized controlled trial. Lancet Oncol. 2009;10:1037–44.PubMedCrossRef Chang EL, Wefel JS, Hess KR, Allen PK, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomized controlled trial. Lancet Oncol. 2009;10:1037–44.PubMedCrossRef
11.
Zurück zum Zitat Gondi V, Mehta MP, Pugh S. Memory preservation with conformal avoidance of the hippocampus during whole brain radiotherapy for patients with brain metastases: primary endpoint results of RTOG 0933. Int J Radiat Oncol Biol Phys. 2013;87(5):1186.CrossRef Gondi V, Mehta MP, Pugh S. Memory preservation with conformal avoidance of the hippocampus during whole brain radiotherapy for patients with brain metastases: primary endpoint results of RTOG 0933. Int J Radiat Oncol Biol Phys. 2013;87(5):1186.CrossRef
12.
Zurück zum Zitat Welzel G, Fleckenstein K, Schaefer J, Hermann B, et al. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys. 2008;72:1311–8.PubMedCrossRef Welzel G, Fleckenstein K, Schaefer J, Hermann B, et al. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys. 2008;72:1311–8.PubMedCrossRef
13.
Zurück zum Zitat Catt S, Chalmers A, Critchley G, Fallowfield L. Supportive follow up in patients treated with radical intent for high grade glioma. CNS Oncol. 2012;1(1):39–48.PubMedCrossRef Catt S, Chalmers A, Critchley G, Fallowfield L. Supportive follow up in patients treated with radical intent for high grade glioma. CNS Oncol. 2012;1(1):39–48.PubMedCrossRef
14.••
Zurück zum Zitat Kerrigan S, Erridge S, Liaquat I, Graham C, Grant R. Mental incapacity in patients undergoing neuro-oncologic treatment: a cross-sectional study. Neurology. 2014;83(6):537–41. This paper examines the relationship between capacity to give consent for surgery and cognitive testing and the value of the verbal fluency test (animals) in identifying patients that require more detailed assessment.PubMedCrossRef Kerrigan S, Erridge S, Liaquat I, Graham C, Grant R. Mental incapacity in patients undergoing neuro-oncologic treatment: a cross-sectional study. Neurology. 2014;83(6):537–41. This paper examines the relationship between capacity to give consent for surgery and cognitive testing and the value of the verbal fluency test (animals) in identifying patients that require more detailed assessment.PubMedCrossRef
15.
Zurück zum Zitat Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, et al. Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments. Neuro-Oncology. 2013;15(1):122–9.PubMedPubMedCentralCrossRef Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, et al. Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments. Neuro-Oncology. 2013;15(1):122–9.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Kerrigan S, Rooney A, Grant R. Measuring cognitive function in people with brain tumours using the Addenbrooke’s cognitive examination. J Neurol Neurosurg Psychiatry. 2012;83:1.CrossRef Kerrigan S, Rooney A, Grant R. Measuring cognitive function in people with brain tumours using the Addenbrooke’s cognitive examination. J Neurol Neurosurg Psychiatry. 2012;83:1.CrossRef
17.
Zurück zum Zitat Davie GL, Hutcheson KA, Barringer DA. Aphasia in patients after brain tumor resection. Aphasiology. 2009;23(9):1196–206.CrossRef Davie GL, Hutcheson KA, Barringer DA. Aphasia in patients after brain tumor resection. Aphasiology. 2009;23(9):1196–206.CrossRef
18.
Zurück zum Zitat Finch E, Copland DA. Language outcomes following neurosurgery for brain tumours: a systematic review. NeuroRehabilitation. 2014;34:499–514.PubMed Finch E, Copland DA. Language outcomes following neurosurgery for brain tumours: a systematic review. NeuroRehabilitation. 2014;34:499–514.PubMed
19.
Zurück zum Zitat Satoer D, Visch-Brink E, Smits M, Kloet A, Looman C, Dirven C, et al. Long-term evaluation of cognition after glioma surgery in eloquent areas. J Neurooncol. 2014;116:153–60.PubMedCrossRef Satoer D, Visch-Brink E, Smits M, Kloet A, Looman C, Dirven C, et al. Long-term evaluation of cognition after glioma surgery in eloquent areas. J Neurooncol. 2014;116:153–60.PubMedCrossRef
20.
Zurück zum Zitat Racine AC, Li J, Molinaro A, Butowski N, Berger MS. Neurocognitive function in newly diagnosed low-grade glioma patients undergoing surgical resection with awake mapping techniques. Neurosurgery. 2015;77(3):371–9.PubMedCrossRef Racine AC, Li J, Molinaro A, Butowski N, Berger MS. Neurocognitive function in newly diagnosed low-grade glioma patients undergoing surgical resection with awake mapping techniques. Neurosurgery. 2015;77(3):371–9.PubMedCrossRef
21.
Zurück zum Zitat Klein M, Duffau H, de Witt Hamer PC. Cognition and respective surgery for diffuse infiltrative glioma: an overview. J Neurooncol. 2012;108:309–18.PubMedPubMedCentralCrossRef Klein M, Duffau H, de Witt Hamer PC. Cognition and respective surgery for diffuse infiltrative glioma: an overview. J Neurooncol. 2012;108:309–18.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Klein M, Taphoorn MJB, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, et al. Neurobehavioral status and health-related quality of life in newly diagnosed high grade glioma patients. J Clin Oncol. 2001;19(20):4037–47.PubMed Klein M, Taphoorn MJB, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, et al. Neurobehavioral status and health-related quality of life in newly diagnosed high grade glioma patients. J Clin Oncol. 2001;19(20):4037–47.PubMed
23.
Zurück zum Zitat Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology. 1996;47:1396–402.PubMedCrossRef Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology. 1996;47:1396–402.PubMedCrossRef
24.••
Zurück zum Zitat Rooney AG, Brown PD, Reijneveld JC, et al. Depression in glioma: a primer for clinicians and researchers. J Neurol Neurosurg Psychiatry. 2014;85:230–5. This paper summarises the potential role of depression and antidepressants in glioma and effects on neurorehabilitation.PubMedCrossRef Rooney AG, Brown PD, Reijneveld JC, et al. Depression in glioma: a primer for clinicians and researchers. J Neurol Neurosurg Psychiatry. 2014;85:230–5. This paper summarises the potential role of depression and antidepressants in glioma and effects on neurorehabilitation.PubMedCrossRef
25.
Zurück zum Zitat Folstein M, Folstein SE, McHugh PR. “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef Folstein M, Folstein SE, McHugh PR. “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef
26.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.PubMedCrossRef Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.PubMedCrossRef
27.
Zurück zum Zitat Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000;55:1613–20.PubMedCrossRef Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000;55:1613–20.PubMedCrossRef
28.
Zurück zum Zitat Brown PD, Buckner JC, O’Fallon JR, Iturria NL, O’Neill BP, Brown CA, et al. Importance of baseline Mini-Mental State Examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys. 2004;59:117–25.PubMedCrossRef Brown PD, Buckner JC, O’Fallon JR, Iturria NL, O’Neill BP, Brown CA, et al. Importance of baseline Mini-Mental State Examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys. 2004;59:117–25.PubMedCrossRef
29.
Zurück zum Zitat Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts or sensitivity. J Clin Oncol. 2003;21:3557–8.PubMedCrossRef Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts or sensitivity. J Clin Oncol. 2003;21:3557–8.PubMedCrossRef
31.
Zurück zum Zitat Noll KR, Bradshaw ME, Weinberg JS, Wefel JS. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma. Psycho-Oncology. 2016. doi:10.1002/pon.4046. Noll KR, Bradshaw ME, Weinberg JS, Wefel JS. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma. Psycho-Oncology. 2016. doi:10.​1002/​pon.​4046.
32.
Zurück zum Zitat Wefel JS, Vardy J, Ahles T, Schagen SB. International cognition and cancer task force recommendations to harmonize studies of cognitive function in patients with cancer. Lancet Oncol. 2001;12:703–8.CrossRef Wefel JS, Vardy J, Ahles T, Schagen SB. International cognition and cancer task force recommendations to harmonize studies of cognitive function in patients with cancer. Lancet Oncol. 2001;12:703–8.CrossRef
33.
Zurück zum Zitat Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: therapy and clinical interpretation. Tucson: Neuropsychological Press; 1985. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: therapy and clinical interpretation. Tucson: Neuropsychological Press; 1985.
34.
Zurück zum Zitat Benedict RHB, Schretien D, Groninger L, Brandt J. Hopkins Verbal Learning Test—revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43–55.CrossRef Benedict RHB, Schretien D, Groninger L, Brandt J. Hopkins Verbal Learning Test—revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43–55.CrossRef
35.
Zurück zum Zitat Benton AL, Hannay HJ, Varney NR. Visual perception of line direction in patients with unilateral brain disease. Neurology. 1975;25:907–10.PubMedCrossRef Benton AL, Hannay HJ, Varney NR. Visual perception of line direction in patients with unilateral brain disease. Neurology. 1975;25:907–10.PubMedCrossRef
36.
Zurück zum Zitat Benton AL, Hamsher K. Multilingual Aphasia examination. Iowa City: AJA Associates; 1989. Benton AL, Hamsher K. Multilingual Aphasia examination. Iowa City: AJA Associates; 1989.
37.
Zurück zum Zitat Wechsler D. Wechsler adult intelligence scale – revised. San Antonia: The Psychological Corporation; 1981. Wechsler D. Wechsler adult intelligence scale – revised. San Antonia: The Psychological Corporation; 1981.
38.
Zurück zum Zitat Stewart AL, Ware JE. Measuring functioning and well-being: the medical outcomes study approach. Durham: Duke University; 1992. Stewart AL, Ware JE. Measuring functioning and well-being: the medical outcomes study approach. Durham: Duke University; 1992.
39.••
Zurück zum Zitat Gehring K, Sitskoorn MM, Gundy CM, Sikkes SAM, Klein M, Postma TJ, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol. 2009;27:3712–22. This paper emphasizes the importance of cognitive rehabilitation in selected patients post treatment and evidence of longer term benefits.PubMedCrossRef Gehring K, Sitskoorn MM, Gundy CM, Sikkes SAM, Klein M, Postma TJ, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol. 2009;27:3712–22. This paper emphasizes the importance of cognitive rehabilitation in selected patients post treatment and evidence of longer term benefits.PubMedCrossRef
40.
Zurück zum Zitat Aaronson NK, Taphoorn MJ, Heimans JJ, Postma TJ, Gundy CM, Beute GN, et al. Compromised health-related quality of life in patients with low grade glioma. J Clin Oncol. 2011;29:4430–5.PubMedCrossRef Aaronson NK, Taphoorn MJ, Heimans JJ, Postma TJ, Gundy CM, Beute GN, et al. Compromised health-related quality of life in patients with low grade glioma. J Clin Oncol. 2011;29:4430–5.PubMedCrossRef
41.
Zurück zum Zitat Gehring K, Taphoorn MJ, Sitskoon MM, Aaronson NK. Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma. Neuro-Oncol Pract. 2015;2:20–31.CrossRef Gehring K, Taphoorn MJ, Sitskoon MM, Aaronson NK. Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma. Neuro-Oncol Pract. 2015;2:20–31.CrossRef
42.
Zurück zum Zitat Fox SW, Lyon D, Farace E. Symptom clusters in patients with highgrade glioma. J Nurs Scholarsh. 2007;39:61–7.PubMedCrossRef Fox SW, Lyon D, Farace E. Symptom clusters in patients with highgrade glioma. J Nurs Scholarsh. 2007;39:61–7.PubMedCrossRef
43.
Zurück zum Zitat Lovely MP, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiformae. Oncol Nurs Forum. 1999;26:921–5.PubMed Lovely MP, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiformae. Oncol Nurs Forum. 1999;26:921–5.PubMed
44.
Zurück zum Zitat Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57:41–9.PubMedCrossRef Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57:41–9.PubMedCrossRef
45.
Zurück zum Zitat Powell C, Guerrero D, Sardell S, et al. Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. Radiother Oncol. 2011;100:131–6.PubMedCrossRef Powell C, Guerrero D, Sardell S, et al. Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. Radiother Oncol. 2011;100:131–6.PubMedCrossRef
46.
Zurück zum Zitat Struik K, Klein M, Heimans JJ, Gielissen MF, et al. Fatigue in low-grade glioma. J Neuro-Oncol. 2009;92(1):73–8.CrossRef Struik K, Klein M, Heimans JJ, Gielissen MF, et al. Fatigue in low-grade glioma. J Neuro-Oncol. 2009;92(1):73–8.CrossRef
47.
Zurück zum Zitat Taphoorn MJ, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol. 1994;36:48–54.PubMedCrossRef Taphoorn MJ, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol. 1994;36:48–54.PubMedCrossRef
48.
Zurück zum Zitat Valentine AD, Meyers CA. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer. 2001;92(6):1694–8.PubMedCrossRef Valentine AD, Meyers CA. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer. 2001;92(6):1694–8.PubMedCrossRef
49.
Zurück zum Zitat Butler Jr JM, Case LD, Atkins J, Frizzel B, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007;69:1496–501.PubMedCrossRef Butler Jr JM, Case LD, Atkins J, Frizzel B, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumour patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007;69:1496–501.PubMedCrossRef
50.
Zurück zum Zitat Boele FW, Douw L, de Groot M, van Thuijl HF, Cleijne W, Heimans JJ, et al. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro Oncol. 2013;15(10):1420–8.PubMedPubMedCentralCrossRef Boele FW, Douw L, de Groot M, van Thuijl HF, Cleijne W, Heimans JJ, et al. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro Oncol. 2013;15(10):1420–8.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive benefits in patients with cancer. Expert Rev Anticancer Ther. 2012;12(2):255–69.PubMedCrossRef Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive benefits in patients with cancer. Expert Rev Anticancer Ther. 2012;12(2):255–69.PubMedCrossRef
52.
Zurück zum Zitat Armstrong TS, Cron SG, Bolanos EV, Gilbert MR, Kang DH. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 2010;116(11):2707–15.PubMed Armstrong TS, Cron SG, Bolanos EV, Gilbert MR, Kang DH. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 2010;116(11):2707–15.PubMed
53.
Zurück zum Zitat Rooney A, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2010;103:1–16. Rooney A, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2010;103:1–16.
54.
Zurück zum Zitat Joyce PR. Epidemiology of mood disorders. In: MG Gelder et al., eds. New Oxford Textbook of Psychiatry, 2nd ed. New York: Oxford University Press. Ch 4.5.4; 2000 Joyce PR. Epidemiology of mood disorders. In: MG Gelder et al., eds. New Oxford Textbook of Psychiatry, 2nd ed. New York: Oxford University Press. Ch 4.5.4; 2000
55.
Zurück zum Zitat Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012;366:1310–8.PubMedCrossRef Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012;366:1310–8.PubMedCrossRef
56.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef
58.
Zurück zum Zitat National Institute for Clinical Excellence (NICE). Depression: the treatment and management of depression in adults (partial update of NICE clinical guideline 23). London: National Institute for Health and Clinical Excellence; 2009. National Institute for Clinical Excellence (NICE). Depression: the treatment and management of depression in adults (partial update of NICE clinical guideline 23). London: National Institute for Health and Clinical Excellence; 2009.
59.
Zurück zum Zitat Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 2013;31(5):1–19. Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 2013;31(5):1–19.
60.
Zurück zum Zitat Hackett ML, Anderson CS, House A, et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008;4:1–92. Hackett ML, Anderson CS, House A, et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008;4:1–92.
61.
Zurück zum Zitat Ostuzzi G, Matcham F, Dauchy S, et al. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev. 2015; Issue 6. Art Ostuzzi G, Matcham F, Dauchy S, et al. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev. 2015; Issue 6. Art
62.
Zurück zum Zitat Alper K, Schwartz KA, Kolts RL, et al. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) Summary Basis of Approval reports. Biol Psychiatry. 2007;62:345–54.PubMedCrossRef Alper K, Schwartz KA, Kolts RL, et al. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) Summary Basis of Approval reports. Biol Psychiatry. 2007;62:345–54.PubMedCrossRef
63.
Zurück zum Zitat Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59:35–41.PubMedCrossRef Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59:35–41.PubMedCrossRef
64.
Zurück zum Zitat National Institute for Clinical Excellence (NICE). Depression in adults with a chronic physical health problem: treatment and management. London: National Institute for Health and Clinical Excellence; 2009. National Institute for Clinical Excellence (NICE). Depression in adults with a chronic physical health problem: treatment and management. London: National Institute for Health and Clinical Excellence; 2009.
65.
Zurück zum Zitat Angst J. Course and prognosis of mood disorders. In: Gelder MG et al., editors. New Oxford textbook of psychiatry. 2nd ed. New York: Oxford University Press; 2009. Angst J. Course and prognosis of mood disorders. In: Gelder MG et al., editors. New Oxford textbook of psychiatry. 2nd ed. New York: Oxford University Press; 2009.
66.
Zurück zum Zitat Rooney AG, McNamara S, Mackinnon M, et al. Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol. 2011;29:4307–12.PubMedCrossRef Rooney AG, McNamara S, Mackinnon M, et al. Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol. 2011;29:4307–12.PubMedCrossRef
67.
Zurück zum Zitat Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Insomnia among brain tumor patients: a population-based prospective study of tumor patients in Northern Finland. J Psychosoc Oncol. 2013;31(5):507–16.PubMedCrossRef Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Insomnia among brain tumor patients: a population-based prospective study of tumor patients in Northern Finland. J Psychosoc Oncol. 2013;31(5):507–16.PubMedCrossRef
68.
Zurück zum Zitat Mandrell BN, Wise M, Schoumacher RA, Pritchard M, et al. Excessive daytime sleepiness and sleep-disordered breathing disturbances in survivors of childhood central nervous system tumors. Pediatr Blood Cancer. 2012;58:746–51.PubMedPubMedCentralCrossRef Mandrell BN, Wise M, Schoumacher RA, Pritchard M, et al. Excessive daytime sleepiness and sleep-disordered breathing disturbances in survivors of childhood central nervous system tumors. Pediatr Blood Cancer. 2012;58:746–51.PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Harjani RR, Janaki MG, Krishnaswamy UM, Alva RC, Ponni A, et al. Epworth sleepiness scale—a novel tool to assess somnolence syndrome post radiotherapy to brain. Int J Cancer Ther Oncol. 2015;3(1):1–4. Harjani RR, Janaki MG, Krishnaswamy UM, Alva RC, Ponni A, et al. Epworth sleepiness scale—a novel tool to assess somnolence syndrome post radiotherapy to brain. Int J Cancer Ther Oncol. 2015;3(1):1–4.
70.
Zurück zum Zitat Verberne LM, Maurice-Stam H, Grootenhuis MA, Santen H, Van Meeteren AYN. Sleep disorders in children after treatment for a CNS tumour. J Sleep Res. 2012;21:461–9.PubMedCrossRef Verberne LM, Maurice-Stam H, Grootenhuis MA, Santen H, Van Meeteren AYN. Sleep disorders in children after treatment for a CNS tumour. J Sleep Res. 2012;21:461–9.PubMedCrossRef
71.
Zurück zum Zitat Kaleyias J, Manley P, Kothare SV. (2012). Sleep disorders in children with cancer, vol 19. Seminars in Pediatric Neurology. Elsevier Kaleyias J, Manley P, Kothare SV. (2012). Sleep disorders in children with cancer, vol 19. Seminars in Pediatric Neurology. Elsevier
72.
Zurück zum Zitat Waltel LM, Nixon GM, Davey MJ, Downie PA, Horne RSC. Sleep and fatigue in pediatric oncology: a review of the literature. Sleep Med Rev. 2015;24:71–82.CrossRef Waltel LM, Nixon GM, Davey MJ, Downie PA, Horne RSC. Sleep and fatigue in pediatric oncology: a review of the literature. Sleep Med Rev. 2015;24:71–82.CrossRef
73.
Zurück zum Zitat Provini F, Lombardi C, Lugaresi E. Insomnia in neurological diseases. Semin Neurol. 2005;25:81–9.PubMedCrossRef Provini F, Lombardi C, Lugaresi E. Insomnia in neurological diseases. Semin Neurol. 2005;25:81–9.PubMedCrossRef
74.••
Zurück zum Zitat Armstrong TS, Gilbert MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro-Oncology. 2012;14:65–72. This paper emphasizes practical strategies that may help patients improve fatigue levels and thus improve engagement with cognitive rehabilitation. Armstrong TS, Gilbert MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro-Oncology. 2012;14:65–72. This paper emphasizes practical strategies that may help patients improve fatigue levels and thus improve engagement with cognitive rehabilitation.
75.
Zurück zum Zitat Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.PubMedPubMedCentral Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.PubMedPubMedCentral
76.
Zurück zum Zitat Berger AM. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum. 2009;36(4):165–77.CrossRef Berger AM. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum. 2009;36(4):165–77.CrossRef
77.
Zurück zum Zitat Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocinol Metab. 2006;87:3993–6.CrossRef Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocinol Metab. 2006;87:3993–6.CrossRef
78.
Zurück zum Zitat Han EY, Chun MH, Kim BR, Kim HJ. Functional improvement after 4-week rehabilitation therapy and effects of attention deficit in brain tumour patients: comparison with subacute stroke patients. Ann Rehabil Med. 2015;39(4):560–9.PubMedPubMedCentralCrossRef Han EY, Chun MH, Kim BR, Kim HJ. Functional improvement after 4-week rehabilitation therapy and effects of attention deficit in brain tumour patients: comparison with subacute stroke patients. Ann Rehabil Med. 2015;39(4):560–9.PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Zucchella C, Capone A, Codella V, De Nunzio AM, et al. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. J Neuro- Oncol. 2013;114(1):93–100.CrossRef Zucchella C, Capone A, Codella V, De Nunzio AM, et al. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. J Neuro- Oncol. 2013;114(1):93–100.CrossRef
80.
Zurück zum Zitat Butler J, Rapp S, Shaw E. Managing the cognitive effects of brain tumour radiation therapy. Curr Treat Options in Oncol. 2006;7(6):517–23.CrossRef Butler J, Rapp S, Shaw E. Managing the cognitive effects of brain tumour radiation therapy. Curr Treat Options in Oncol. 2006;7(6):517–23.CrossRef
81.
Zurück zum Zitat Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, et al. Clinical course and progression-free survival of adult intracranial and spinal epedymoma patients. Neuro Oncol. 2015;17(3):440–7.PubMedPubMedCentral Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, et al. Clinical course and progression-free survival of adult intracranial and spinal epedymoma patients. Neuro Oncol. 2015;17(3):440–7.PubMedPubMedCentral
82.••
Zurück zum Zitat Khan F, Amatya B, Ng L, Drummond K, Galea M. Multidisciplinary rehabilitation after primary brain tumour treatment. Cochrane Database Syst Rev. 2015;8:1–49. This is a high quality systematic review of neuro-rehabilitation in patients with brain tumours. Khan F, Amatya B, Ng L, Drummond K, Galea M. Multidisciplinary rehabilitation after primary brain tumour treatment. Cochrane Database Syst Rev. 2015;8:1–49. This is a high quality systematic review of neuro-rehabilitation in patients with brain tumours.
83.
Zurück zum Zitat Khan F, Amatya B, Drummon K, Galea M. Effectiveness of integrated multidisciplinary rehabilitation in primary brain cancer survivors in an Australian community cohort: a controlled clinical trial. J Rehabil Med. 2014;46:754–60.PubMedCrossRef Khan F, Amatya B, Drummon K, Galea M. Effectiveness of integrated multidisciplinary rehabilitation in primary brain cancer survivors in an Australian community cohort: a controlled clinical trial. J Rehabil Med. 2014;46:754–60.PubMedCrossRef
84.
Zurück zum Zitat Piil K, Juhler M, Jakobsen J, Jarden M. Controlled rehabilitative and supportive care intervention trials in patients with high grade gliomas and their caregivers: a systematic review. BMJ Supportive & Palliative Care. 2014; 0:1–8. Piil K, Juhler M, Jakobsen J, Jarden M. Controlled rehabilitative and supportive care intervention trials in patients with high grade gliomas and their caregivers: a systematic review. BMJ Supportive & Palliative Care. 2014; 0:1–8.
85.
Zurück zum Zitat Day J, Zienius K, Gehring K, Grosshans D, Taphoorn M, Grant R, et al. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. Cochrane Database Syst Rev. 2014;12:1–62. Day J, Zienius K, Gehring K, Grosshans D, Taphoorn M, Grant R, et al. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. Cochrane Database Syst Rev. 2014;12:1–62.
86.
Zurück zum Zitat Locke D, Cerhan J, Wu W, Malec J, Clark M, Rummans T, et al. Cognitive rehabilitation and problem solving to improve quality of life of patients with primary brain tumors: a pilot study. J Support Oncol. 2008;6(8):383–91.PubMed Locke D, Cerhan J, Wu W, Malec J, Clark M, Rummans T, et al. Cognitive rehabilitation and problem solving to improve quality of life of patients with primary brain tumors: a pilot study. J Support Oncol. 2008;6(8):383–91.PubMed
87.
Zurück zum Zitat Brown PD, Pugh S, Laack NN, Wefel JS, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013;15(10):1429–37.PubMedPubMedCentralCrossRef Brown PD, Pugh S, Laack NN, Wefel JS, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013;15(10):1429–37.PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Malak A, Diramali A, Yucesoy K. Effects of counselling on some care outcomes among patients with a brain tumor: pain, seizure, constipation, infection, dispatch conditions. Neuro Oncol. 2010;6(2):25–31. Malak A, Diramali A, Yucesoy K. Effects of counselling on some care outcomes among patients with a brain tumor: pain, seizure, constipation, infection, dispatch conditions. Neuro Oncol. 2010;6(2):25–31.
89.
Zurück zum Zitat Cavers D, Hacking B, Erridge SE, Kendall M, Morris PG & Murray SA. Social, psychological and existential well-being in patients with glioma and their caregivers: a qualitative study. CMAJ. 2012;184(7):E373–82. doi:10.1503/cmaj.111622. Cavers D, Hacking B, Erridge SE, Kendall M, Morris PG & Murray SA. Social, psychological and existential well-being in patients with glioma and their caregivers: a qualitative study. CMAJ. 2012;184(7):E373–82. doi:10.​1503/​cmaj.​111622.
91.
Zurück zum Zitat Cashman R, Bernstein L, Bilodeau D, Bovett G, Jackson B, Yousefi M, et al. Evaluation of an educational program for the caregivers of persons diagnosed with a malignant glioma. Can Oncol Nurs J. 2007;17(1):6–15.PubMedCrossRef Cashman R, Bernstein L, Bilodeau D, Bovett G, Jackson B, Yousefi M, et al. Evaluation of an educational program for the caregivers of persons diagnosed with a malignant glioma. Can Oncol Nurs J. 2007;17(1):6–15.PubMedCrossRef
92.
Zurück zum Zitat Flechl B, Marosi C. Austrian patients with glioblastoma multiforme and their families: socioeconomic aspects. Eur Assoc Neuro-Oncol Mag. 2013;3(2):46–8. Flechl B, Marosi C. Austrian patients with glioblastoma multiforme and their families: socioeconomic aspects. Eur Assoc Neuro-Oncol Mag. 2013;3(2):46–8.
94.
Zurück zum Zitat Bartolo M, Zucchella C, Pace A, Lanzetta G, et al. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumors. J Neurooncol. 2012;107:537–44.PubMedCrossRef Bartolo M, Zucchella C, Pace A, Lanzetta G, et al. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumors. J Neurooncol. 2012;107:537–44.PubMedCrossRef
95.
Zurück zum Zitat Boele F, Hoeben W, Hilverda K, Lenting J, Calis A, Sizoo E, et al. Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomised controlled trial. J Neurooncol. 2013;111(3):303–11.PubMedCrossRef Boele F, Hoeben W, Hilverda K, Lenting J, Calis A, Sizoo E, et al. Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomised controlled trial. J Neurooncol. 2013;111(3):303–11.PubMedCrossRef
96.
Zurück zum Zitat Rosenberg A, Dussel V, Kang T, Geyer J, Gerhardt C, Feudtner C, et al. Psychological distress in parents of children with advanced cancer. JAMA Paediatr. 2013;167(6):537–43.CrossRef Rosenberg A, Dussel V, Kang T, Geyer J, Gerhardt C, Feudtner C, et al. Psychological distress in parents of children with advanced cancer. JAMA Paediatr. 2013;167(6):537–43.CrossRef
Metadaten
Titel
Neurocognitive Deficits and Neurocognitive Rehabilitation in Adult Brain Tumors
verfasst von
Julia Day, BSc (Hons), MScR
David C. Gillespie, MA (Hons), ClinPsyD, PhD, MSc (Fam Therapy), CPsychol
Alasdair G. Rooney, MBChB, MD
Helen J. Bulbeck, PhD
Karolis Zienius, MBChB, BSc
Florien Boele, PhD
Robin Grant, MBChB, MD
Publikationsdatum
01.05.2016
Verlag
Springer US
Erschienen in
Current Treatment Options in Neurology / Ausgabe 5/2016
Print ISSN: 1092-8480
Elektronische ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-016-0406-5

Weitere Artikel der Ausgabe 5/2016

Current Treatment Options in Neurology 5/2016 Zur Ausgabe

Sleep Disorders (A Iranzo, Section Editor)

Sleep-Related Epilepsy

Movement Disorders (A Videnovich, Section Editor)

Myoclonus: Pathophysiology and Treatment Options

Neurologic Manifestations of Systemic Disease (N Scolding and C Rice, Section Editors)

Behçet’s Disease and Nervous System Involvement

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.